Global Fentanyl Transdermal Patches
Market Report
2024
Fentanyl Transdermal Patches Market size is USD XX million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.10% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Fentanyl Transdermal Patches Market Report 2024.
According to Cognitive Market Research, the global Fentanyl Transdermal Patches market size is USD XX million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.10% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Fentanyl Transdermal Patches Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.1% |
North America Fentanyl Transdermal Patches Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.3% |
Europe Fentanyl Transdermal Patches Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.6% |
Asia Pacific Fentanyl Transdermal Patches Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.1% |
South America Fentanyl Transdermal Patches Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.5% |
Middle East and Africa Fentanyl Transdermal Patches Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.8% |
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Fentanyl Transdermal Patches industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Fentanyl Transdermal Patches Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Pharmaceutical preparations called fentanyl transdermal patches are made to allow the powerful opioid drug fentanyl to enter the bloodstream through the skin and relieve pain. Patients with chronic pain often utilize these patches, particularly when other pain treatment techniques have not worked well. The Fentanyl Transdermal Patches market is being driven by the growing chronic pain, rising product launch, increasing geriatric population, technological advancements and growing cancer cases.
The increased frequency of chronic pain issues, such as neuropathic pain, pain associated with cancer, and pain from musculoskeletal disorders, is driving the need for effective pain management therapies like fentanyl transdermal patches. For example, a recent systematic analysis including studies from 2014 to 2021 found that 44% of cancer patients felt overall discomfort, per the National Institutes of Health study. 31% of the patients (as opposed to 38% of people in a 2016 review) reported having moderate-to-severe pain. 55% of patients with advanced metastatic and terminal cancer reported having discomfort, down from 66% in a 2016 analysis.
Diseases associated with age including degenerative disc disorders and arthritis that cause chronic pain are more common as the world's population ages. The demand for painkillers, such as fentanyl patches, is fueled by this demographic shift. For instance, as per the World Health Organization report, among the musculoskeletal disorders, osteoarthritis is one of the major contributors to years lived with disability. Osteoarthritis is more common in the elderly (about 70% of those over 55), hence as the population ages, it is anticipated that its prevalence will rise globally. Osteoarthritis usually develops in the late 40s to mid-50s, although it can occasionally strike younger people, especially athletes and those who have had joint damage or injury. Women make for about 60% of the osteoarthritis population.
(Source: https://www.who.int/news-room/fact-sheets/detail/osteoarthritis).
Medication, constipation, sleepiness, lightheadedness, and itching at the patch site are typical adverse effects of fentanyl patches. One should speak with a healthcare professional about these adverse effects. A fatal overdose might result from the excessive potency of fentanyl if it is used inappropriately. When it comes to dosage and patch application, patients need to adhere to their doctor's orders. In order to prevent the potentially fatal release of fentanyl in one go, it is imperative that you do not cut, chew, or tamper with the patches.
Production and delivery of pharmaceutical products, particularly fentanyl patches, were delayed and shortages resulted from the pandemic's disruption of global supply networks and manufacturing processes. The supply of these patches in some areas was impacted by manufacturers' struggles to get raw materials, keep workers available, and comply with regulations. Also, patients' choices for pain relief measures may have been impacted by worries about visiting medical facilities during the pandemic. Self-administered transdermal patches provide an at-home treatment option that may have grown more enticing to certain patients during the pandemic, particularly those who are more susceptible to COVID-19 problems.
We have various report editions of Fentanyl Transdermal Patches Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The competitive landscape of the Fentanyl Transdermal Patches market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts
In October 2023, the National Medical Products Administration (NMPA) of China has approved Luye Pharma Group's novel medicine, Rivastigmine Twice Weekly Transdermal Patch, for the symptomatic treatment of mild to severe Alzheimer's disease (AD). Luye Pharma developed the medicine on their own transdermal patch platform in Europe. Luye Pharma and Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci) collaborated to manage the drug's commercialization in China.
Top Companies Market Share in Fentanyl Transdermal Patches Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Global Fentanyl Transdermal Patches Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Fentanyl Transdermal Patches Industry growth. Fentanyl Transdermal Patches market has been segmented with the help of its Type, Application , and others. Fentanyl Transdermal Patches market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, 12 mcg/h type stands out as the dominating category. Patients with moderate to severe chronic pain who need a lower dosage of fentanyl for successful pain management may be prescribed the 12 mcg/h fentanyl patch. This might apply to people who have neuropathic pain, osteoarthritis, or chronic back pain.
25 mcg/h type emerges as the fastest-growing category in the Fentanyl Transdermal Patches market. A number of factors, including the frequency of conditions needing strong opioid analgesia, healthcare professionals' prescribing patterns, patient preferences, and regulatory concerns, may affect the demand for the 25 mcg/h fentanyl patch. Demand for this strength may be higher in areas with higher rates of cancer or other severe chronic pain problems.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Fentanyl Transdermal Patches Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the dominating category is Cancer Pain. Pain related to cancer is a typical symptom that both patients receiving treatment and those with advanced stages of the disease feel. The need for efficient pain management techniques, such as fentanyl patches and other opioid drugs, is fueled by the incidence of cancer-related pain.
The fastest-growing category in the Fentanyl Transdermal Patches market is Post-operative Pain. Long-lasting pain relief is offered by fentanyl patches, which usually last 48 to 72 hours each patch. This feature qualifies them for the management of post-operative pain that needs continuous care and lasts longer than the acute period.
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Fentanyl Transdermal Patches market report 2024 Edition by contacting our team.
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. Neural pain, musculoskeletal diseases, and pain associated with cancer are among the many chronic pain issues that a large portion of the North American population suffers from. Because of this, there is a need for efficient pain relief options, such as fentanyl patches.
Asia-Pacific stands out as the fastest-growing region in the Fentanyl Transdermal Patches market. The Asia Pacific region is home to several nations that are making investments in their hospitals, clinics, and pharmaceutical production plants. The research, manufacturing, and delivery of pharmaceutical products—including fentanyl transdermal patches—are made easier by this infrastructural expansion
The current report Scope analyzes Fentanyl Transdermal Patches Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
According to Cognitive Market Research, the global Fentanyl Transdermal Patches market size was estimated at USD XX Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.3% from 2024 to 2031. In North America, the Fentanyl Transdermal Patches market exhibits a promising landscape characterized by increasing prevalence of cancer. Regional analysis reveals that the United States and Canada are the primary contributors to market growth, driven by the rising collaboration and increasing investment. Segmentation analysis further highlights 12 mcg/h, 25 mcg/h, 50 mcg/h, 75 mcg/h, 100 mcg/h growth at a rapid rate in the region, due to the rising investments. In conclusion, North America presents a lucrative market opportunity for Fentanyl Transdermal Patches manufacturers, driven by growing product launch, increasing investment and growing prevalence of cancer.
According to Cognitive Market Research, the global Fentanyl Transdermal Patches market size was estimated at USD XX Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.6% from 2024 to 2031. In Europe, the Fentanyl Transdermal Patches market presents a dynamic landscape characterized by increasing investment and regulatory support. Regional analysis indicates that countries like Germany, the UK, and Russia are the key contributors to market growth, driven by factors such as a strong economy, increasing investments, and growing product launch. Segmentation analysis further highlights the adoption of different categories in the region, with cancer pain is the dominant categories. In conclusion, Europe represents a lucrative market for Fentanyl Transdermal Patches manufacturers, driven by rising investment and rising product launch.
According to Cognitive Market Research, the global Fentanyl Transdermal Patches market size was estimated at USD XX Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031. In the Asia Pacific region, the Fentanyl Transdermal Patches market exhibits robust growth prospects driven by growing healthcare infrastructrure and rising cases of cancer. Regional analysis indicates that countries such as China, Japan, South Korea, and India are key contributors to market expansion, with growing investment and increasing product launches. Segmentation analysis reveals a diverse range of type such as 12 mcg/h, 25 mcg/h, 50 mcg/h, 75 mcg/h, 100 mcg/h to cater to different consumer bases. In conclusion, the Asia Pacific region presents immense growth opportunities for Fentanyl Transdermal Patches manufacturers, fueled by rising product launches, growing healthcare infrastructure and rising cases of cancer.
According to Cognitive Market Research, the global Fentanyl Transdermal Patches market size was estimated at USD XX Million out of which the Latin America market is more than 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031. In Latin America, the Fentanyl Transdermal Patches market showcases promising growth prospects driven by rising product launches. Regional analysis indicates that countries like Brazil, Mexico, Argentina, and Chile are significant contributors to market growth, supported by growing investment. Segmentation analysis reveals a diverse range of type including 12 mcg/h, 25 mcg/h, 50 mcg/h, 75 mcg/h, 100 mcg/h. In conclusion, Latin America presents significant growth opportunities for Fentanyl Transdermal Patches manufacturers, driven by favourable market conditions and increasing investment.
According to Cognitive Market Research, the global Fentanyl Transdermal Patches market size was estimated at USD XX Million out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031. MEA the Fentanyl Transdermal Patches market showcases promising growth prospects driven by factors such as rising product launch and increasing investment. Segmentation analysis reveals a diverse range of type of Fentanyl Transdermal Patches in Middle East and Africa, including 12 mcg/h, 25 mcg/h, 50 mcg/h, 75 mcg/h, 100 mcg/h. In conclusion, Middle East and Africa presents significant growth opportunities for Fentanyl Transdermal Patches manufacturers, driven by favourable market conditions and growing innovative product launch.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
I am a dedicated and detail-oriented research analyst, committed to unraveling the stories hidden within data. With a solid foundation in market research & analysis, I thrive in the dynamic realm of research, where every dataset presents an opportunity for discovery. My passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.
I am committed to continuous professional development, regularly participating in workshops, attending conferences, and staying attuned to emerging trends in research methodologies to maintain the highest standards in my work. I played a vital role in conducting market research and competitive analysis. I have a proven track record of synthesizing diverse datasets, employing statistical models, and presenting comprehensive insights. My collaborative approach with cross-functional teams facilitated effective communication of findings, fostering a culture of data-driven decision-making within the organization.
Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Type | 12 mcg/h, 25 mcg/h, 50 mcg/h, 75 mcg/h, 100 mcg/h |
Application | Musculoskeletal Pain, Auto-immune Disease, Post-operative Pain, Cancer Pain, Others |
List of Competitors | Noven Pharmaceuticals, Inc, ProSolus, Inc, Tapemark, tesa Tapes Pvt. Ltd., Nitto Denko Corporation, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Medherant Limited, Bayer AG, Corium, Inc., Novartis AG, Antares Pharma, Abbott, Medipatch, Inc., Mylan N.V., Acrux Limited, Sparsha Pharma International Pvt Ltd, Bliss GVS Pharma, Johnson & Johnson, Informa PLC |
This chapter will help you gain GLOBAL Market Analysis of Fentanyl Transdermal Patches. Further deep in this chapter, you will be able to review Global Fentanyl Transdermal Patches Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Chapter 2 North America Market Analysis
Executive Summary North America Market (2019 vs 2024 vs 2031)
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
Qualitative Analysis for the North America Market: North America Fentanyl Transdermal Patches Market Trends North America Fentanyl Transdermal Patches Technological Road Map North America Fentanyl Transdermal Patches Market Drivers North America Fentanyl Transdermal Patches Market Restraints North America Fentanyl Transdermal Patches Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
Chapter 3 Europe Market Analysis
Chapter 4 Asia-Pacific Market Analysis
Chapter 5 South America Market Analysis
Chapter 6 Middle East and Africa Market Analysis
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Fentanyl Transdermal Patches market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why 12 mcg/h have a significant impact on Fentanyl Transdermal Patches market? |
What are the key factors affecting the 12 mcg/h and 25 mcg/h of Fentanyl Transdermal Patches Market? |
What is the CAGR/Growth Rate of Musculoskeletal Pain during the forecast period? |
By type, which segment accounted for largest share of the global Fentanyl Transdermal Patches Market? |
Which region is expected to dominate the global Fentanyl Transdermal Patches Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Fentanyl Transdermal Patches Market
Request Sample